Global Orthopedic Biomaterial Market Size, Share, Forecast Report, 2020-2027

Orthopedic biomaterials are synthetic or organic materials. They are used for internal fracture fixation. Orthopedic biomaterials are commonly used in orthopedics, surgical implants, prosthetics, and various medical tools and devices.

The global orthopedic biomaterial market is majorly driven by the increasing older population leading to increase in the patient population, increasing surgeries, the various government supports, and growing awareness among young population towards health.

According to the United Nations, approximately over 962 million people were aged over 60 and above globally in 2017. The United Nations has also estimated that by 2050, the number of older population is likely to reach 425 million. This increasing aging population is likely to boost the growth of the global orthopedic biomaterial market.

Factors such as rigorous clinical and regulatory processes are likely to hamper the growth of the orthopedic biomaterial market.

Global orthopedic biomaterial market is expected to grow at a CAGR of 10.5% during the forecast period.
Segments

The global orthopedic biomaterials market is segmented on the basis of types of material, application, and end-user.

On the basis of types of material, the market is segmented into metals and non-metals. The metals are further sub-segmented into titanium alloy, stainless steel, cobalt alloy, and others. Non-metals are further sub-segmented into polymeric, natural biomaterials, ceramic, and others. Ceramics are sub-segmented into alumina, zirconium dioxide, calcium phosphate, carbon, and others. Polymeric materials are sub-segmented into polyester, silicone, polyethylene, polymethylmethacrylate (PMMA), and others. Natural biomaterials are sub-segmented into chitin and chitosan, collagen, and others.

On the basis of application, the market is segmented into joint replacement, spine implants, fracture fixation devices, tissue fixation, viscosupplementation, and others. Joint replacement is sub-segmented into shoulder and elbow replacement, hip replacement, knee replacement, and others. Tissue fixation is sub-segmented into suture anchors, interference screws, and others. The fracture fixation devices are sub-segmented into screws, plates for bones, rods, and others.

On the basis of end-user, the market is segmented into hospitals, clinics, and others.Key Players

Some of the key players in the orthopedic biomaterial market are CoorsTek Inc., CERADYNE, Straumann, Stryker, Kyocera Corporation, Materion Corporation, 3M ESPE, Nobel Biocare Services AG, Morgan Advanced Materials, and DePuy Synthes.